AVSU
American Century ETF Trust - Avantis Responsible U.S. Equity ETF

2
Loading...
Loading...
News
all
press releases
Pfizer CEO Reportedly Says Vaccine Approvals Getting Harder
According to a report from Bloomberg, Bourla said that it's harder to get vaccine approvals and not drug approvals.
Stocktwits·1d ago
News Placeholder
More News
News Placeholder
UnitedHealth Shareholder Proposes Distinct Chairman And Chief Executive Roles: Report
Stephen Hemsley currently serves as both CEO and Chairman of the Board.
Stocktwits·13d ago
News Placeholder
Rivian Slashes Full-Year Delivery Guidance Amid Uncertainty Related To Federal EV Tax Credit Expiry
The company slashed its delivery guidance to 41,500 to 43,500 vehicles for the full year.
Stocktwits·14d ago
News Placeholder
General Motors Reports 7.7% Growth In Q3 Auto Sales In US
Electric vehicle sales in the quarter hit a fresh record of 66,501 units as customers rushed to make their EV purchase before the expiry of the federal tax credit of $7,500 on September 30.
Stocktwits·15d ago
News Placeholder
Acadia Pharmaceuticals’ Investigational Drug For Rare Genetic Disorder Fails In Late-Stage Study
The company noted that the safety and tolerability of intranasal Carbetocin were consistent with those observed in previous clinical trials.
Stocktwits·22d ago
News Placeholder
Emergent BioSolutions Stock Rises After Receiving Fresh International Purchase Orders: Retail Says Stock Is ‘Significantly Undervalued’
The order encompasses multiple product offerings within Emergent’s medical countermeasures business, including countermeasures for threats posed by Smallpox, Anthrax, and Botulism.
Stocktwits·27d ago
News Placeholder
RH Stock Sees Slew Of Downgrades, Price Target Cuts From Wall Street As Trump Tariffs Bite
Telsey Advisory Group stated that if an additional sector tariff on furniture is imposed, RH has the highest exposure within the home furnishings coverage group due to a high percentage of sales from furniture and limited sourcing in the U.S.
Stocktwits·1mo ago
News Placeholder
Maze Therapeutics Stock Just Shot Up 56% Pre-Market Today – Here’s What Happened
The company announced a private placement for over four million shares of common stock at $16.25 apiece, representing a premium of over 1% from the stock’s closing price on Wednesday.
Stocktwits·1mo ago
News Placeholder
IONS Stock Soars 34% To Hit February 2021 Highs After Medicine Shows Positive Effect On Elevated Triglyceride Levels In Late-Stage Studies
In two studies, Ionis’ Olezarsen demonstrated a highly statistically significant placebo-adjusted mean reduction in fasting triglycerides of up to 72% at six months.
Stocktwits·1mo ago

Latest AVSU News

View

Advertisement|Remove ads.

Advertisement|Remove ads.